Synergys Biotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Synergys Biotherapeutics Inc (Synergys Biotherapeutics) is an antibody therapeutic company that develops multifunctional anti-vasculogenic and immuno-oncology antibody therapeutics. The companys pipeline portfolio includes multifunctional anti-vasculogenic antibody fusion molecule for the treatment of triple negative breast cancer (TNBC); a therapeutic targeted for ovarian cancer and for HER2+ breast cancer; and a fully human bi-targeted antibody for the treatment of pancreatic cancer with applications in other cancer areas and ocular and inflammatory diseases. It offers its immune-oncology platform to increase potency of antibodies and generate multifunctional product candidates. The company in-licenses its early stage candidates to other companies for late-stage product development and commercialization. Its immune-oncology platform utilizes a tumor targeting antibody and immune effector molecule of specific immune cells to generate inhibition of tumor growth. Synergys Biotherapeutics is headquartered in Walnut Creek, California, the US.
Synergys Biotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Synergys Biotherapeutics Inc (Synergys Biotherapeutics) is an antibody therapeutic company that develops multifunctional anti-vasculogenic and immuno-oncology antibody therapeutics. The companys pipeline portfolio includes multifunctional anti-vasculogenic antibody fusion molecule for the treatment of triple negative breast cancer (TNBC); a therapeutic targeted for ovarian cancer and for HER2+ breast cancer; and a fully human bi-targeted antibody for the treatment of pancreatic cancer with applications in other cancer areas and ocular and inflammatory diseases. It offers its immune-oncology platform to increase potency of antibodies and generate multifunctional product candidates. The company in-licenses its early stage candidates to other companies for late-stage product development and commercialization. Its immune-oncology platform utilizes a tumor targeting antibody and immune effector molecule of specific immune cells to generate inhibition of tumor growth. Synergys Biotherapeutics is headquartered in Walnut Creek, California, the US.
Synergys Biotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
3
List of Tables 4
List of Figures 4
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Synergys Biotherapeutics Enters into Research Agreement with US University 10
Licensing Agreements 11
Synergys Biotherapeutics Enters into Licensing Agreement with US University 11
Synergys Biotherapeutics Enters into Licensing Agreement with South Korean Pharma Company 12
Synergys Biotherapeutics Inc - Key Competitors 13
Synergys Biotherapeutics Inc - Key Employees 14
Synergys Biotherapeutics Inc - Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
09/26/2017: SYNERGYS Announces Phase 1 SBIR Grant Award From National Institutes of Health 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List Of Tables
List of TablesSynergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synergys Biotherapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Synergys Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Synergys Biotherapeutics Enters into Research Agreement with US University 10
Synergys Biotherapeutics Enters into Licensing Agreement with US University 11
Synergys Biotherapeutics Enters into Licensing Agreement with South Korean Pharma Company 12
Synergys Biotherapeutics Inc, Key Competitors 13
Synergys Biotherapeutics Inc, Key Employees 14
RELATED REPORTS
Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review
Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to
View ReportGene Biotherapeutics Inc (CRXM) - Strategic SWOT Analysis Review
Gene Biotherapeutics Inc (CRXM) - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
